1. Home
  2. AXSM vs BOOT Comparison

AXSM vs BOOT Comparison

Compare AXSM & BOOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXSM
  • BOOT
  • Stock Information
  • Founded
  • AXSM 2012
  • BOOT 1978
  • Country
  • AXSM United States
  • BOOT United States
  • Employees
  • AXSM N/A
  • BOOT N/A
  • Industry
  • AXSM Biotechnology: Pharmaceutical Preparations
  • BOOT Clothing/Shoe/Accessory Stores
  • Sector
  • AXSM Health Care
  • BOOT Consumer Discretionary
  • Exchange
  • AXSM Nasdaq
  • BOOT Nasdaq
  • Market Cap
  • AXSM 5.1B
  • BOOT 5.1B
  • IPO Year
  • AXSM 2015
  • BOOT 2014
  • Fundamental
  • Price
  • AXSM $116.78
  • BOOT $181.54
  • Analyst Decision
  • AXSM Strong Buy
  • BOOT Strong Buy
  • Analyst Count
  • AXSM 17
  • BOOT 13
  • Target Price
  • AXSM $175.76
  • BOOT $189.77
  • AVG Volume (30 Days)
  • AXSM 591.0K
  • BOOT 465.2K
  • Earning Date
  • AXSM 11-11-2025
  • BOOT 10-27-2025
  • Dividend Yield
  • AXSM N/A
  • BOOT N/A
  • EPS Growth
  • AXSM N/A
  • BOOT 29.02
  • EPS
  • AXSM N/A
  • BOOT 6.36
  • Revenue
  • AXSM $495,033,000.00
  • BOOT $1,991,785,000.00
  • Revenue This Year
  • AXSM $64.05
  • BOOT $15.85
  • Revenue Next Year
  • AXSM $56.46
  • BOOT $13.10
  • P/E Ratio
  • AXSM N/A
  • BOOT $28.32
  • Revenue Growth
  • AXSM 69.83
  • BOOT 16.70
  • 52 Week Low
  • AXSM $75.56
  • BOOT $86.17
  • 52 Week High
  • AXSM $139.13
  • BOOT $191.31
  • Technical
  • Relative Strength Index (RSI)
  • AXSM 47.95
  • BOOT 53.96
  • Support Level
  • AXSM $123.54
  • BOOT $181.38
  • Resistance Level
  • AXSM $130.00
  • BOOT $189.44
  • Average True Range (ATR)
  • AXSM 3.66
  • BOOT 6.67
  • MACD
  • AXSM -0.95
  • BOOT -0.09
  • Stochastic Oscillator
  • AXSM 4.51
  • BOOT 53.40

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

About BOOT Boot Barn Holdings Inc.

Boot Barn Holdings Inc operates specialty retail stores. The company sells western and work-related footwear, apparel, and accessories in the United States. It is a single operating segment, which includes net sales generated from its retail stores and e-commerce websites.

Share on Social Networks: